Acellera and Psivant have announced a strategic research partnership aimed at developing computational drug discovery ...

The potential secretary for Health and Human Services has been forced to defend his previous anti-vaccine stances at his ...

Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO, succeeding Jessica ...

AstraZeneca and Daiichi Sankyo ’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from ...

The FDA has granted RMAT designation to Beacon Therapeutics’ gene therapy, laru-zova, for treating X-linked retinitis pigmentosa (XLRP).

The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.